| Heading: |
Pregnancy: Sodium Valproate |
| Question ID: |
1812897 |
| UIN: |
60057 |
| House: |
Commons |
| Date tabled: |
2025-06-16 |
| Asking Member ID: |
4436 |
| Asking Member display name: |
Cat Smith
|
| Asking Member handle: |
CatSmithMP
|
| Asking Member Twitter reference: |
@CatSmithMP
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support (a) GPs and (b) other healthcare professionals to distribute the pregnancy prevention program for people prescribed Sodium Valproate. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-30 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Medicines and Healthcare products Regulatory Agency (MHRA), taking advice from the Commission on Human Medicines (CHM), has worked to raise awareness among healthcare professionals and patients of the risks of valproate when taken during pregnancy thr... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |